Breathomix

medical devices

About

Breathomix is a Dutch SME focused on advanced exhaled breath analysis technology for clinical diagnostics. Founded in June 2018 by researchers from Amsterdam University Medical Centres, the company combines over 30 years of expertise in breathomics, cloud computing, IoT, and artificial intelligence to create non-invasive diagnostic solutions. The main product, the BreathBase® Solution, utilizes eNose technology to analyze volatile organic compounds (VOCs) in exhaled breath. These VOCs act as biomarkers for various diseases, allowing for early detection and classification of conditions such as cancer and infections. Breathomix aims to make breath analysis as routine as blood testing, enhancing early disease detection and supporting precision medicine. The company collaborates with hardware suppliers to optimize breath sampling devices and integrates cloud applications and AI to aid in data analysis and clinical decision-making. Their target market includes healthcare providers, hospitals, and home care settings, promoting breath analysis as a standard practice in healthcare.

Technologies

Outlook Microsoft Office 365 Mobile Friendly AI

Keywords

precision medicine machine learning data driven medicine breath analysis research artificial intelligence biomarkers cloud applications breathomics big data analysis medical devices clinical data integration reproducible measurements cloud calibration medical diagnostics enose technology data-driven medicine sensor technology non-invasive diagnostics pattern recognition biological information in breath health monitoring via breath cloud analysis medical and diagnostic laboratories biotechnology metabolic changes detection ai-powered analysis personalized treatment early disease detection molecular pattern recognition

Location

200 Bargelaan, Leiden, South Holland, Netherlands, 2333 CW

Related Companies

Companies in the same industry